Cancer

Titlesort descending Average Rating
Ukrain treatment in a patient with breast carcinoma 70.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Ukrain treatment in carcinoma of the oesophagus (case report) 70.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats 40.00%
Ukrain: Debated Subjects 80.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 60.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 90.00%
Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. 90.00%
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. 60.00%
Vitamin D and prostate cancer risk: a review of the epidemiological literature. 60.00%
Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. 90.00%
Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prosta 90.00%
Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice. 80.00%
Vitamin D for cancer prevention: global perspective. 90.00%
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. 80.00%
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug 90.00%
Why are tumour blood vessels abnormal and why is it important to know? 90.00%
Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retar
Why is not Ukrain approved yet in Austria/EU? 98.57%
Why We Get Sick And How to Get Well 90.00%
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside. 80.00%
WITHDRAWN: Ovarian ablation for early breast cancer. 50.00%

Pages